As shown in Table 2, NSCLC patients with different clinical characteristics, such as sex, age, histological type and tumor-node-metastasis (TNM) stage, demonstrated similar levels of GSK3β. This evidence concerns the gene GSK3B and non-small cell lung carcinoma.